serum reduction
Recently Published Documents


TOTAL DOCUMENTS

11
(FIVE YEARS 2)

H-INDEX

7
(FIVE YEARS 0)

Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2616
Author(s):  
Jorge Briseño-Bugarín ◽  
Isabel Hernández-Ochoa ◽  
Xelha Araujo-Padilla ◽  
María Angélica Mojica-Villegas ◽  
Ricardo Iván Montaño-González ◽  
...  

Cyclophosphamide (CP)—which is used to treat autoimmune diseases and cancer—is related to gonadotoxicity attributed to oxidative stress. As phycobiliproteins (PBPs) are strong antioxidants that are unexplored as protective agents against male gonadotoxicity, our work aimed to investigate the effects of PBP crude extract on testicular damage and sperm parameter alterations caused by CP in mice. Three doses of PBP (50, 100, and 200 mg/kg) were tested in the experimental groups (n = 8 per group), administered concomitantly with 100 mg/kg CP. After 42 days receiving PBP daily and CP weekly, body and relative testicular weights, serum testosterone levels, testicular lipoperoxidation and antioxidant enzyme activity levels, and testicular histology and sperm parameter alterations were assessed. The results showed that PBP crude extract at 200 mg/kg prevented testosterone serum reduction, body weight loss, lipoperoxidation and enzyme activity increments, and sperm parameter alterations and partially ameliorated relative testicular weight reductions and histological damage in CP-treated mice. In conclusion, we showed that PBP crude extract (200 mg/kg) mitigated oxidative damage in the testes and ameliorated alterations in sperm parameters in mice treated with CP (100 mg/kg); therefore, PBP extract could be considered as a potential protective agent against CP toxicity.


Author(s):  
Karolina Bochon ◽  
Katarzyna Zielniok ◽  
Maciej Gawlak ◽  
Katarzyna Zawada ◽  
Weronika Zarychta-Wiśniewska ◽  
...  

2013 ◽  
Vol 335 (1) ◽  
pp. 175-182 ◽  
Author(s):  
Hye Jin Jee ◽  
Hyun-Ju Kim ◽  
Ae Jeong Kim ◽  
Naree Song ◽  
Minjee Kim ◽  
...  

2013 ◽  
Vol 46 (3) ◽  
pp. 300-311 ◽  
Author(s):  
K. H. Chua ◽  
F. Raduan ◽  
W. K. Z. Wan Safwani ◽  
N. F. M. Manzor ◽  
B. Pingguan‐Murphy ◽  
...  

2010 ◽  
Vol 109 (5) ◽  
pp. 1515-1523 ◽  
Author(s):  
Robert D. Hyldahl ◽  
Kevin S. O'Fallon ◽  
Lawrence M. Schwartz ◽  
Priscilla M. Clarkson

Skeletal muscle atrophy is a significant health problem that results in decreased muscle size and function and has been associated with increases in oxidative stress. The molecular mechanisms that regulate muscle atrophy, however, are largely unknown. The metallothioneins (MT), a family of genes with antioxidant properties, have been found to be consistently upregulated during muscle atrophy, although their function during muscle atrophy is unknown. Therefore, we hypothesized that MT knockdown would result in greater oxidative stress and an enhanced atrophy response in C2C12 myotubes subjected to serum reduction (SR), a novel atrophy-inducing stimulus. Forty-eight hours before SR, myotubes were transfected with small interfering RNA (siRNA) sequences designed to decrease MT expression. Muscle atrophy and oxidative stress were then measured at baseline and for 72 h following SR. Muscle atrophy was quantified by immunocytochemistry and myotube diameter measurements. Oxidative stress was measured using the fluorescent probe 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein. SR resulted in a significant increase in oxidative stress and a decrease in myotube size and protein content. However, there were no differences observed in the extent of muscle atrophy or oxidant activity following MT knockdown. We therefore conclude that the novel SR model results in a strong atrophy response and an increase in oxidant activity in cultured myotubes and that knockdown of MT does not affect that response.


2010 ◽  
Vol 468 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Maria Elephteria Evangelopoulos ◽  
Stefan Wüller ◽  
Joachim Weis ◽  
Alexander Krüttgen

2006 ◽  
Vol 74 (3) ◽  
pp. 1580-1587 ◽  
Author(s):  
Christine A. Petersen ◽  
Katherine A. Krumholz ◽  
John Carmen ◽  
Anthony P. Sinai ◽  
Barbara A. Burleigh

ABSTRACT Studies of cardiac pathology and heart failure have implicated cardiomyocyte apoptosis as a critical determinant of disease. Recent evidence indicates that the intracellular protozoan parasite Trypanosoma cruzi, which causes heart disease in chronically infected individuals, impinges on host apoptotic pathways in a cell type-dependent manner. T. cruzi infection of isolated neuronal cells and cardiomyocytes protects against apoptotic cell death, whereas apoptosis is triggered in T cells in T. cruzi-infected animals. In this study, we demonstrate that the ability of T. cruzi to protect cardiac cells in vitro from apoptosis triggered by a combination of tumor necrosis factor alpha and serum reduction correlates with the presence of intracellular parasites and involves activation of host cell NF-κB. We further demonstrate that the apoptotic block diminishes activation of caspase 3. The ability of T. cruzi to prevent apoptosis of infected cardiomyocytes is likely to play an important role in establishment of persistent infection in the heart while minimizing potential damage and remodeling that is associated with cardiomyocyte apoptosis in cardiovascular disease.


1995 ◽  
Vol 78 (2) ◽  
pp. 538-542 ◽  
Author(s):  
Mark A Poli ◽  
Kathleen S Rein ◽  
Daniel G Baden

Abstract Antiserum against PbTx-2-type brevetoxins was produced by immunizing rabbits with a PbTx-2–bovine serum albumin (BSA) conjugate. This serum had a higher affinity, but lower titer, than our current goat serum. Using 4 natural brevetoxins and 6 synthetic derivatives as competitors in our brevetoxin radioimmunoassay, we determined the epitope specificity of both sera. Modification of the backbone structure at C-42 on the K-ring had little or no effect on the antigen-binding capability of either serum. Reduction of the double bond between C-2 and C-3 on the A-ring by reduction of the lactone decreased binding 500 to 750-fold. Epoxidation of the double bond between C-27 and C-28 on the H-ring did not affect binding, which suggested that the goat serum is specific for the A-ring region of the brevetoxin backbone. In contrast, modifying the A-ring had no effect on rabbit serum binding. However, epoxidation of the H-ring decreased binding 5 to 20-fold, which suggested that the rabbit antiserum is specific for the H-ring region of the molecule. These results suggest that assays utilizing only one antibody may not adequately detect toxin metabolites if molecules are altered in the critical region of antibody recognition.


1989 ◽  
Vol 9 (10) ◽  
pp. 4196-4203
Author(s):  
A J Fornace ◽  
D W Nebert ◽  
M C Hollander ◽  
J D Luethy ◽  
M Papathanasiou ◽  
...  

More than 20 different cDNA clones encoding DNA-damage-inducible transcripts in rodent cells have recently been isolated by hybridization subtraction (A. J. Fornace, Jr., I. Alamo, Jr., and M. C. Hollander, Proc. Natl. Acad. Sci. USA 85:8800-8804, 1988). In most cells, one effect of DNA damage is the transient inhibition of DNA synthesis and cell growth. We now show that five of our clones encode transcripts that are increased by other growth cessation signals: growth arrest by serum reduction, medium depletion, contact inhibition, or a 24-h exposure to hydroxyurea. The genes coding for these transcripts have been designated gadd (growth arrest and DNA damage inducible). Two of the gadd cDNA clones were found to hybridize at high stringency to transcripts from human cells that were induced after growth cessation signals or treatment with DNA-damaging agents, which indicates that these responses have been conserved during mammalian evolution. In contrast to results with growth-arrested cells that still had the capacity to grow after removal of the growth arrest conditions, no induction occurred in HL60 cells when growth arrest was produced by terminal differentiation, indicating that only certain kinds of growth cessation signals induce these genes. All of our experiments suggest that the gadd genes are coordinately regulated: the kinetics of induction for all five transcripts were similar; in addition, overexpression of gadd genes was found in homozygous deletion c14CoS/c14CoS mice that are missing a small portion of chromosome 7, suggesting that a trans-acting factor encoded by a gene in this deleted portion is a negative effector of the gadd genes. The gadd genes may represent part of a novel regulatory pathway involved in the negative control of mammalian cell growth.


Sign in / Sign up

Export Citation Format

Share Document